Skip to main content
Premium Trial:

Request an Annual Quote

Horizon Secures Exclusive License to Cell Lines from UMB

NEW YORK (GenomeWeb News) – Horizon Discovery has licensed exclusive worldwide rights to a panel of human isogenic disease models developed by researchers from the University of Maryland, Baltimore, the firm said today.

The cell lines were developed using Horizon's Genesis platform. They will be added to the firm's X-Man cell models, which the Cambridge, UK-based firm said enables drug discovery researchers to "understand how cancer manifests itself in real patients and helps rationalize many aspects of drug development, and therefore the final cost of new personalized cancer therapies."

Horizon will pay the University of Maryland, Baltimore, up-front fees and royalties on product sales. The term of the license is seven years.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.